Astellas Pharma Inc.

2016 Revenue (US$ Millions)$11,215
Revenue Growth (%)-4.45%
Net Income (US$ Millions)$1,870
Earnings Per Share (US$)$0.89
EPS Growth Rate (%)15.54%
Profit Margin16.67%
Total Equity (US$ Millions)$10,874
Return on Equity (%)17.37%
Long Term Debt (US$ Millions)$0
Debt To Equity Ratio (%)0.00%
Total Assets (US$ Millions)$15,569
Current Assets (US$ Millions)$7,495
Current Liabilities (US$ Millions)$3,419
Cost of Goods Sold (US$ Millions)$2,740
Inventory Turnover1.86